Prnay is currently a Senior Manager at Moderna, where he leads analytical method strategy across late-phase and commercial mRNA programs. His work focuses on the qualification, validation, transfer, and lifecycle management of analytical methods across a global manufacturing network, ensuring that novel science can be reliably scaled and sustained in real-world, regulated environments. Prior to this, Prnay held leadership roles at Gritstone bio, where he helped develop and operationalize platforms for personalized cancer vaccines and infectious disease programs.

Earlier in his career, he conducted research at Boston Children’s Hospital and Harvard Medical School, exploring neurogenetics and brain circuitry. He also developed and led a summer academic program in neuroscience and psychology for high school students, expanding access to advanced scientific education and creating curriculum elements that continue to be used today. Across his academic and industry experience, he has been recognized for his ability to bridge disciplines - connecting scientific innovation with strategy, operations, and communication.

He spent the years of 2016-2018 pursuing advanced, full-time classical dance training in India. Training in an extremely complex and philosophically intensive art form has honed his skills of discipline, insight, and perception, which has further enhanced his scientific approach. These deeply cross-cultural and cross-disciplinary experiences have made him a demonstrated innovator, translator, and collaborator within both biotechnology and art, allowing him to develop insights and connections across scientific areas that are traditionally siloed.